Results of two worldwide surveys into physician awareness and perceptions of extended-spectrum β-lactamases
Open Access
- 1 August 2004
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 10 (8) , 760-762
- https://doi.org/10.1111/j.1469-0691.2004.00957.x
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Outcome of Cephalosporin Treatment for Serious Infections Due to Apparently Susceptible Organisms Producing Extended-Spectrum β-Lactamases: Implications for the Clinical Microbiology LaboratoryJournal of Clinical Microbiology, 2001
- Extended-Spectrum -Lactamase-Producing Escherichia coli and Klebsiella pneumoniae: Risk Factors for Infection and Impact of Resistance on OutcomesClinical Infectious Diseases, 2001
- New -Lactamases in Gram-Negative Bacteria: Diversity and Impact on the Selection of Antimicrobial TherapyClinical Infectious Diseases, 2001
- MYSTIC (Meropenem Yearly Susceptibility Test Information Collection): a global overview.Journal of Antimicrobial Chemotherapy, 2000
- Bacterial Pathogens Isolated from Patients with Bloodstream Infection: Frequencies of Occurrence and Antimicrobial Susceptibility Patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)Antimicrobial Agents and Chemotherapy, 1998
- A multicentre collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992-1993: The Alexander ProjectJournal of Antimicrobial Chemotherapy, 1996
- beta-Lactamases in laboratory and clinical resistanceClinical Microbiology Reviews, 1995